TORONTO, ON. (May 2, 2019) – GMP Capital Inc. (GMP) (TSX: GMP or the Company) today announced that the nine nominees listed in the Company’s management information circular (the Circular) dated March 22, 2019, were elected as directors of GMP. The detailed results of the vote for the election of directors held at GMP’s Annual Meeting of Common Shareholders (the Meeting) on Thursday, May 2, 2019, in Toronto, Ontario, are set out below.
Election of Directors
By a vote conducted by show of hands, each of the nine nominees listed in the Circular was elected to serve as a director of GMP until the next annual meeting or until his or her successor is elected or appointed, with the outcome of the vote being as follows:
Final voting results on all matters voted on at the Meeting held on Thursday, May 2, 2019, can be accessed at www.gmpcapital.com and on SEDAR at www.sedar.com.
ABOUT GMP CAPITAL INC.
GMP is a leading independent diversified financial services firm headquartered in Toronto, Canada, providing a wide range of financial products and services to a global client base that includes corporate clients, institutional investors and high-net-worth individuals in two integrated reporting segments. The Capital Markets segment provides investment banking, including advisory and underwriting services, institutional sales and trading and research through offices in Canada, the United Kingdom, and the Bahamas. Wealth Management consists of GMP’s non-controlling ownership interest in Richardson GMP Limited. Richardson GMP Limited, Canada’s largest independent wealth management firm, is focused on providing exclusive and comprehensive wealth management and investment services delivered by an experienced team of investment professionals. GMP is listed on the Toronto Stock Exchange under the symbol “GMP”. For further information, please visit our corporate website at gmpcapital.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
GMP Capital Inc.
Director, Investor Relations
145 King Street West, Suite 300
Toronto, Ontario M5H 1J8
Tel: (416) 941-0894; Fax: (416) 943-6175
[email protected] or [email protected]